99% Imatinib Intermediate Powder

  • Origin: China
  • Test Method: HPLC
  • Sample: 10-20g Avaliable
  • Our certification: ISO, HACCP, Organic, HALAL, KOSHER, SC
  • Shelf Life: 2 years
  • Delivery Time: 7-15 days
  • Application: Food&beverage
  • OEM&ODM: Powder, capsule, tablet, liquid form
  • Our Packing: 25kg/barrel, 10kg/25kg/Carton, 1kg/5kg/10kg/bag or your request

Product Details

Imatinib Intermediate is an essential medication used in the treatment of certain types of cancer, most notably chronic myeloid leukaemia (CML). 99% Imatinib intermediate powder is a crucial synthetic chemical compound used in the production of Imatinib, a drug that is utilized to treat specific types of cancer. Imatinib intermediate powder is a white or off-white color solid powder that is soluble in organic solvents like methanol, acetone, and acetic acid. The pharmaceutical industry highly relies on this intermediate compound to produce Imatinib as it plays a critical role in the drug synthesis process.

Imatinib intermediate powder is produced through an intricate process that adheres to all the standard requirements for the production of synthetic chemicals. It is generally manufactured in a state-of-the-art facility using advanced equipment and techniques to ensure the highest quality possible. The product undergoes rigorous monitoring and testing to meet the set standards and ensure that it is safe for human use.

Due to its vital role in the production of Imatinib, Imatinib intermediate powder has made a significant impact in the field of medicine. It has helped increase the availability of medication used in fighting against cancer, improving the quality of life for patients worldwide. The pharmaceutical industry’s relentless efforts in manufacturing high-quality intermediates like Imatinib intermediate powder have helped save lives and offered hope to people affected by cancer.

Health Benefits

One key benefit of Imatinib Intermediate is that it works by specifically targeting cancer cells, preventing them from growing and dividing. Unlike traditional treatments such as chemotherapy, which can harm healthy cells as well as cancerous ones, Imatinib Intermediate allows patients to continue with their daily routines and maintain a good quality of life. This is particularly important for those who are already struggling with a serious illness.

Another benefit of Imatinib Intermediate is that it can significantly improve the chances of survival for those with CML. Clinical trials have shown that patients taking Imatinib Intermediate have a much higher chance of living longer than those who don’t. This is because the medication helps to control the progression of the cancer, preventing it from spreading to other parts of the body.

Moreover, Imatinib Intermediate has few side effects when compared to other cancer medications, making it a safer and more comfortable option for patients. Studies have shown that common side effects such as nausea, fatigue and hair loss are minimal with Imatinib Intermediate and can be easily managed. In contrast to other treatments, patients can continue to lead their lives without the severe side effects that often accompany cancer therapies.

Imatinib Intermediate has also been shown to be effective in treating other types of cancer, including gastrointestinal stromal tumours and acute lymphoblastic leukaemia. This versatility allows the medication to be an important tool in the fight against different types of cancer, providing patients with new treatment options and hope for recovery.

In conclusion, Imatinib Intermediate is a medication that offers numerous proven health benefits to cancer patients. By specifically targeting cancer cells, controlling the progression of the disease and providing patients with manageable side effects, this medication is an indispensable tool in the fight against cancer.

* This statement for educational purposes only. It has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Inquiry